1-3 of 3
Mutsumi Hayashi, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Humanized Anti-CD26 Monoclonal Antibody Has Anti-Myeloma Efficacy for the Treatment of High-Risk Multiple Myeloma

Hiroko Nishida, MDPhD, Mutsumi Hayashi, MD, PhD, Chikao Morimoto, MD, PhD, Michiie Sakamoto, MD, PhD, Taketo Yamada, MD,PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4424.
https://doi.org/10.1182/blood.V130.Suppl_1.4424.4424
Published: 2017
Journal Articles

CD26 Is a Novel Target for the Treatment of Tumor Progression and Its Related Osteolytic Bone Disease in Multiple Myeloma

Hiroko Nishida, MD, PhD, Hiroko Madokoro, Hiroshi Suzuki, Mutsumi Hayashi, MD, PhD, Chikao Morimoto, MD, PhD, Michiie Sakamoto, MD, PhD, Taketo Yamada, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 1809.
https://doi.org/10.1182/blood.V126.23.1809.1809
Published: 2015
Journal Articles

Effects of a Histone Deacetylase Inhibitor On Myeloid Leukemia Cell Line with Mixed-Lineage Leukemia Partial Tandem Duplication

Dai Keino, MD, Mutsumi Hayashi, MD, Ryo Ohyama, MD, Mizuho Morimoto, MD, Kensuke Kondoh, MD, Akira Shimada, MD, PhD, Taketo Yamada, MD, PhD, Akitoshi Kinoshita, MD
Journal: Blood
Blood (2012) 120 (21): 4331.
https://doi.org/10.1182/blood.V120.21.4331.4331
Published: 2012